Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Sonoma Biotherapeutics, Inc.
Sonoma Biotherapeutics to Present Preclinical Data from Novel Treg Therapy for Rheumatoid Arthritis at American College of Rheumatology Convergence 2023
November 06, 2023
From
Sonoma Biotherapeutics, Inc.
Via
Business Wire
Sonoma Biotherapeutics to Present Preclinical Data from Novel Treg Cell Therapy at Symposium on Hidradenitis Suppurativa Advances
October 13, 2023
From
Sonoma Biotherapeutics, Inc.
Via
Business Wire
Sonoma Biotherapeutics Appoints Joseph R. Arron, M.D., Ph.D., as Chief Scientific Officer and Mark D. Eisner, M.D., MPH, as Chief Medical Officer
September 29, 2023
From
Sonoma Biotherapeutics, Inc.
Via
Business Wire
Sonoma Biotherapeutics and Regeneron Announce Collaboration to Discover, Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases
March 28, 2023
From
Sonoma Biotherapeutics, Inc.
Via
Business Wire
Tickers
REGN
Sonoma Biotherapeutics to Present Preclinical Data from Novel Treg Cell Therapy for Rheumatoid Arthritis at American College of Rheumatology Convergence 2022
November 10, 2022
From
Sonoma Biotherapeutics, Inc.
Via
Business Wire
Sonoma Biotherapeutics Appoints Jessica Stitt as Chief Financial Officer
September 07, 2022
From
Sonoma Biotherapeutics, Inc.
Via
Business Wire
Sonoma Biotherapeutics Enters Long-Term Lease Agreement to Establish a Treg Cell Therapy R&D and Manufacturing Center
August 24, 2022
From
Sonoma Biotherapeutics, Inc.
Via
Business Wire
Sonoma Biotherapeutics Expands Board of Directors with Appointments of Katina Dorton, J.D., MBA, and John Davis, M.D., MPH
August 17, 2022
From
Sonoma Biotherapeutics, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.